Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease

Related articles

09 Jun 2020 : Errate

Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

Jing Zhang, Yanpeng Li, [...] Bingyuan Wang, Yan Luo, Junping Shi, Baiyun Zhao - Show fewer authors

DOI: 10.12659/MSM.926160

28 Jun 2020 : Database Analysis

Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction

Weiran Dai, Yue Sun, [...] Zhiyuan Jiang, Kuan Du, Ning Xia, Guoqiang Zhong - Show fewer authors

DOI: 10.12659/MSM.922492

19 Mar 2020 : Laboratory Research

The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

Jing Zhang, Yanpeng Li, [...] Bingyuan Wang, Yan Luo, Junping Shi, Baiyun Zhao - Show fewer authors

DOI: 10.12659/MSM.921887

06 Feb 2020 : Animal Research

The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid

Jinshan Wang, Wentao Jiang

DOI: 10.12659/MSM.919220

23 Dec 2019 : Clinical Research

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study

Alihan Oral, Tolga Sahin, [...] Fatih Turker, Erdem Kocak - Show fewer authors

DOI: 10.12659/MSM.920172

08 Feb 2019 : Meta-Analysis

Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis

Jiaxing Liu, Jicheng Xing, [...] Bing Wang, Changyong Wei, Ruining Yang, Yuerong Zhu, Hong Qiu - Show fewer authors

DOI: 10.12659/MSM.912737

01 Oct 2018 : Clinical Research

Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)

Jiayu Wu, Ruinan Zhang, [...] Feng Shen, Ruixu Yang, Da Zhou, Haixia Cao, Guangyu Chen, Qin Pan, Jiangao Fan - Show fewer authors

DOI: 10.12659/MSM.909747

16 May 2017 : Laboratory Research

MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)

Xianchao An, Zonglin Yang, [...] Zhengzhuang An - Show fewer authors

DOI: 10.12659/MSM.901377

19 Oct 2016 : Clinical Research

Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1

Ran Ao, Ying Wang, [...] Jing Tong, Bai-Fang Wang - Show fewer authors

DOI: 10.12659/MSM.897207

16 Dec 2013 : Original article

Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes

Aleksandra Trojak, Małgorzata Waluś-Miarka, [...] Ewa Woźniakiewicz, Maciej T. Małecki, Barbara Idzior-Waluś - Show fewer authors

DOI: 10.12659/MSM.889649

01 Dec 2012

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease

Halina Cichoż-Lach, Krzysztof Celiński, [...] Beata Prozorow-Król, Jarosław Swatek, Maria Słomka, Tomasz Lach - Show fewer authors

DOI: 10.12659/MSM.883601

23 Apr 2012

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania

Jonas Valantinas, Daiva Asta Apanaviciene, [...] Ligita Maroziene, Audrius Sveikata - Show fewer authors

DOI: 10.12659/MSM.882722

29 Aug 2014 : Original article

Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Olcay Ozveren, Orhan Dogdu, [...] Cihan Sengul, Veysel Cinar, Elif Eroglu, Zekeriya Kucukdurmaz, Muzaffer Degertekin - Show fewer authors

DOI: 10.12659/MSM.890741

23 Jul 2018 : Clinical Research

Changing Pattern of Acute Alcohol Intoxications in Children

Ivona Vrkić Boban, Andjelko Vrca, [...] Marijan Saraga - Show fewer authors

DOI: 10.12659/MSM.908841

24 Nov 2017 : Animal Research

Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats

Hua Fan, Xiande Ma, [...] Peng Lin, Qiang Kang, Zhilong Zhao, Lina Wang, Dan Sun, Jiayi Cheng, Yajun Li - Show fewer authors

DOI: 10.12659/MSM.907530

11 Apr 2017 : Original article

Application of Indocyanine Green (ICG) Detection in Evaluating Early Prognosis in Patients with Fatty Liver Disease After Liver Transplantation

Wenjing Wang, Qiang Zhao, [...] Anbin Hu, Xiaoshun He, Xiaofeng Zhu - Show fewer authors

DOI: 10.12659/AOT.901277

02 Nov 2016 : Clinical Research

Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients

Yanjin Hu, Jia Liu, [...] Xuejie Dong, Yuan Xu, Song Leng, Guang Wang - Show fewer authors

DOI: 10.12659/MSM.897924

08 Aug 2014 : Original article

Thiazolidinedione Therapy Versus Lifestyle Recommendation in the Treatment of Post-Liver Transplant Graft Steatosis

Fredrik Åberg, Virve Koljonen, [...] Katriina Nikkilä, Sonja Boyd, Johanna Arola, Helena Isoniemi - Show fewer authors

DOI: 10.12659/AOT.890664

24 Apr 2011

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

Yasar Colak, Oguzhan Ozturk, [...] Ebubekir Senates, Ilyas Tuncer, Elif Yorulmaz, Gupse Adali, Levent Doganay, Feruze Yilmaz Enc - Show fewer authors

DOI: 10.12659/MSM.881749

01 Dec 2009

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease

Tatjana Abel, Janos Feher, [...] Elek Dinya, Mohamed Gamal Eldin, Attila Kovacs - Show fewer authors

30 Mar 2009

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C

Yusuf Yilmaz, Enver Dolar, [...] Engin Ulukaya, Semra Akgoz, Murat Keskin, Murat Kiyici, Omer Yerci, Arzu Yilmaztepe Oral, Cuma Bulent Gul, Selim Gurel, Selim Giray Nak, Macit Gulten - Show fewer authors

30 Mar 2009

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease

Yusuf Yilmaz, Ozlen Atug, [...] Oya Yonal, Deniz Duman, Osman Ozdogan, Nese Imeryuz, Cem Kalayci - Show fewer authors

22 Dec 2005

Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Daad H. Akbar, Abeer H. Kawther